不同方法进行早孕期子痫前期筛查的比较:队列研究
西班牙五个地区八个胎儿医学单位的前瞻性队列研究纳入10110例单胎孕妇,比较三种数学模型与NICE、ACOG评分系统对早孕期子痫前期的预测性能。在固定10%筛查阳性率下,FMF模型对早产型子痫前期的检出率最高,且预测值与观察值相关性最佳,AUC为0.911。
要点
- FMF模型在10%筛查阳性率下检出82.7%的早发型子痫前期和72.7%的早产型子痫前期。
- NICE标准在11%筛查阳性率下检出46.7%的早产型子痫前期,ACOG标准在33.8%筛查阳性率下检出65.9%。
- FMF模型预测值与观察值相关性最佳,AUC为0.911。
核心结论
- 结合母体因素与MAP、UtA-PI和PlGF的数学模型筛查早产型子痫前期的性能优于NICE和ACOG风险评分系统。
- 三种算法总体预测结果相似,但FMF模型在个体水平上表现最佳。
研究设计与样本
- 前瞻性队列研究,2017年9月至2019年12月在西班牙五个地区八个胎儿医学单位开展。
- 纳入10110例单胎妊娠,于11+0至13+6周进行常规超声检查时招募。
主要发现
- 研究人群包括32例(0.3%)早发型子痫前期、72例(0.7%)早产型子痫前期和230例(2.3%)任何子痫前期。
- 在固定10%筛查阳性率下,FMF、Crovetto等和Serra等模型对早发型子痫前期的检出率分别为82.7%(95%CI 69.6-95.8%)、73.8%(95%CI 58.7-88.9%)和79.8%(95%CI 66.1-93.5%)。
- 在固定10%筛查阳性率下,FMF、Crovetto等和Serra等模型对早产型子痫前期的检出率分别为72.7%(95%CI 62.9-82.6%)、69.2%(95%CI 58.8-79.6%)和74.1%(95%CI 64.2-83.9%)。
- 在固定10%筛查阳性率下,FMF、Crovetto等和Serra等模型对任何子痫前期的检出率分别为55.1%(95%CI 48.8-61.4%)、47.1%(95%CI 40.6-53.5%)和53.9%(95%CI 47.4-60.4%)。
- FMF模型预测值与观察值相关性最佳,AUC为0.911(95%CI 0.879-0.943),斜率为0.983(95%CI 0.846-1.120),截距为0.154(95%CI -0.091至0.397)。
关键数值与推荐
- NICE标准在11%筛查阳性率下检出46.7%(95%CI 35.3-58.0%)的早产型子痫前期。
- ACOG标准在33.8%筛查阳性率下检出65.9%(95%CI 55.4-76.4%)的早产型子痫前期。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the predictive performance of three different mathematical models for first-trimester screening of pre-eclampsia (PE), which combine maternal risk factors with mean arterial pressure (MAP), uterine artery pulsatility index (UtA-PI) and serum placental growth factor (PlGF), and two risk-scoring systems. METHODS: This was a prospective cohort study performed in eight fetal medicine units in five different regions of Spain between September 2017 and December 2019. All pregnant women with singleton pregnancy and a non-malformed live fetus attending their routine ultrasound examination at 11 + 0 to 13 + 6 weeks' gestation were invited to participate in the study. Maternal characteristics and medical history were recorded and measurements of MAP, UtA-PI, serum PlGF and pregnancy-associated plasma protein-A (PAPP-A) were converted into multiples of the median (MoM). Risks for term PE, preterm PE (< 37 weeks' gestation) and early PE (< 34 weeks' gestation) were calculated according to the FMF competing-risks model, the Crovetto et al. logistic regression model and the Serra et al. Gaussian model. PE classification was also performed based on the recommendations of the National Institute for Health and Care Excellence (NICE) and the American College of Obstetricians and Gynecologists (ACOG). We estimated detection rates (DR) with their 95% CIs at a fixed 10% screen-positive rate (SPR), as well as the area under the receiver-operating-characteristics curve (AUC) for preterm PE, early PE and all PE for the three mathematical models. For the scoring systems, we calculated DR and SPR. Risk calibration was also assessed. RESULTS: The study population comprised 10 110 singleton pregnancies, including 32 (0.3%) that developed early PE, 72 (0.7%) that developed preterm PE and 230 (2.3%) with any PE. At a fixed 10% SPR, the FMF, Crovetto et al. and Serra et al. models detected 82.7% (95% CI, 69.6-95.8%), 73.8% (95% CI, 58.7-88.9%) and 79.8% (95% CI, 66.1-93.5%) of early PE; 72.7% (95% CI, 62.9-82.6%), 69.2% (95% CI, 58.8-79.6%) and 74.1% (95% CI, 64.2-83.9%) of preterm PE; and 55.1% (95% CI, 48.8-61.4%), 47.1% (95% CI, 40.6-53.5%) and 53.9% (95% CI, 47.4-60.4%) of all PE, respectively. The best correlation between predicted and observed cases was achieved by the FMF model, with an AUC of 0.911 (95% CI, 0.879-0.943), a slope of 0.983 (95% CI, 0.846-1.120) and an intercept of 0.154 (95% CI, -0.091 to 0.397). The NICE criteria identified 46.7% (95% CI, 35.3-58.0%) of preterm PE at 11% SPR and ACOG criteria identified 65.9% (95% CI, 55.4-76.4%) of preterm PE at 33.8% SPR. CONCLUSIONS: The best performance of screening for preterm PE is achieved by mathematical models that combine maternal factors with MAP, UtA-PI and PlGF, as compared to risk-scoring systems such as those of NICE and ACOG. While all three algorithms show similar results in terms of overall prediction, the FMF model showed the best performance at an individual level. © 2024 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Cuenca-Gómez D, De Paco Matallana C, Rolle V, et al. Comparison of different methods of first-trimester screening for preterm pre-eclampsia: cohort study. Ultrasound Obstet Gynecol. 2024. PMID: 38411276. doi:10.1002/uog.27622
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。